Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor angeli's salt

Molecular Pharmacology

Volumn 76, Issue 5, 2009, Pages 1115-1122

  Zeller, Andreas ^a   Wenzl, M Verena ^a   Beretta, Matteo ^a   Stessel, Heike ^a   Russwurm, Michael ^b   Koesling, Doris ^b   Schmidt, Kurt ^a   Mayer, Bernd ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLIN 1 OXYL 3 OXIDE; DITHIOTHREITOL; GUANYLATE CYCLASE; IMIDAZOLINE DERIVATIVE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; SCAVENGER; SUPEROXIDE DISMUTASE; THIOL; TRIOXODINITRATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CATALYSIS; DECOMPOSITION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CATTLE; CELLS, CULTURED; ENZYME ACTIVATION; GUANYLATE CYCLASE; NITRIC OXIDE DONORS; NITRITES; NITROGEN OXIDES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SWINE;

EID: 70350469954     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.059915     Document Type: Article

References (40)

1. Akaike T, Yoshida M, Miyamoto Y, Sato K, Kohno M, Sasamoto K, Miyazaki K, Ueda S, and Maeda H (1993) Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/·NO through a radical reaction. Biochemistry 32:827-832. (Pubitemid 23059363)
2. +, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 318:279-285.
3. Beretta M, Gruber K, Kollau A, Russwurm M, Koesling D, Goessler W, Keung WM, Schmidt K, and Mayer B (2008) Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases. J Biol Chem 283:17873-17880.
4. Booth BP, Tabrizi-Fard MA, and Fung H (2000) Calcitonin gene-related peptidedependent vascular relaxation of rat aorta. An additional mechanism for nitroglycerin. Biochem Pharmacol 59:1603-1609.
5. Costa G, Labadía A, Triguero D, Jiménez E, and García-Pascual A (2001) Nitrergic relaxation in urethral smooth muscle: involvement of potassium channels and alternative redox forms of NO. Naunyn Schmiedebergs Arch Pharmacol 364:516-523. (Pubitemid 33145091)
6. DeMaster EG, Redfern B, and Nagasawa HT (1998) Mechanisms of inhibition of aldehyde dehydrogenase by nitroxyl, the active metabolite of the alcohol deterrent agent cyanamide. Biochem Pharmacol 55:2007-2015. (Pubitemid 28477471)
7. Dierks EA and Burstyn JN (1996) Nitric oxide (NO), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase. Biochem Pharmacol 51:1593-1600. (Pubitemid 126333983)
8. Dutton AS, Fukuto JM, and Houk KN (2004) Mechanisms of HNO and NO production from Angeli's salt: density functional and CBS-QB3 theory predictions. J Am Chem Soc 126:3795-3800.
9. Ellis A, Lu H, Li CG, and Rand MJ (2001) Effects of agents that inactivate free radical NO (NO*) on nitroxyl anion-mediated relaxations, and on the detection of NO* released from the nitroxyl anion donor Angeli's salt. Br J Pharmacol 134: 521-528. (Pubitemid 32977896)
10. Evgenov OV, Pacher P, Schmidt PM, Haskó G, Schmidt HH, and Stasch JP (2006) NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5:755-768. (Pubitemid 44323702)
11. Favaloro JL and Kemp-Harper BK (2007) The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature. Cardiovasc Res 73:587-596.
12. Friebe A and Koesling D (2003) Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 93:96-105. (Pubitemid 36919696)
13. Friebe A, Malkewitz J, Schultz G, and Koesling D (1996) Positive effects of pollution? Nature 382:120.
14. Griffiths C, Wykes V, Bellamy TC, and Garthwaite J (2003) A new and simple method for delivering clamped nitric oxide concentrations in the physiological range: application to activation of guanylyl cyclase-coupled nitric oxide receptors. Mol Pharmacol 64:1349-1356. (Pubitemid 37532225)
15. Hewett SJ, Espey MG, Uliasz TF, and Wink DA (2005) Neurotoxicity of nitroxyl: insights into HNO and NO biochemical imbalance. Free Rad Biol Med 39:1478-1488.
16. - activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries. Hypertension 41: 1301-1307.
17. Irvine JC, Favaloro JL, Widdop RE, and Kemp-Harper BK (2007) Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae. Hypertension 49:885-892.
18. Irvine JC, Ritchie RH, Favaloro JL, Andrews KL, Widdop RE, and Kemp-Harper BK (2008) Nitroxyl (HNO): the Cinderella of the nitric oxide story. Trends Pharmacol Sci 29:601-608.
19. Li CG, Karagiannis J, and Rand MJ (1999) Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle. Br J Pharmacol 127:826-834. (Pubitemid 29295340)
20. -): a substrate for superoxide dismutase. Arch Biochem Biophys 402:166-171.
21. Lopez BE, Wink DA, and Fukuto JM (2007) The inhibition of glyceraldehyde-3- phosphate dehydrogenase by nitroxyl (HNO). Arch Biochem Biophys 465:430-436.
22. Mayer B, Klatt P, Werner ER, and Schmidt K (1995) Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem 270:655-659.
23. Mayer B, Kleschyov AL, Stessel H, Russwurm M, Münzel T, Koesling D, and Schmidt K (2009) Inactivation of soluble guanylate cyclase by stoichiometric S-nitrosation. Mol Pharmacol 75:886-891.
24. Miller TW, Cherney MM, Lee AJ, Francoleon NE, Farmer PJ, King SB, Hobbs AJ, Miranda KM, Burstyn JN, and Fukuto JM (2009) The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols. J Biol Chem 284:21788-21796.
25. Miranda KM, Dutton AS, Ridnour LA, Foreman CA, Ford E, Paolocci N, Katori T, Tocchetti CG, Mancardi D, Thomas DD, et al. (2005) Mechanism of aerobic decomposition of Angeli's salt (sodium trioxodinitrate) at physiological pH. J Am Chem Soc 127:722-731. (Pubitemid 40178747)
26. Miranda KM, Paolocci N, Katori T, Thomas DD, Ford E, Bartberger MD, Espey MG, Kass DA, Feelisch M, Fukuto JM, et al. (2003) A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system. Proc Natl Acad Sci U S A 100:9196-9201. (Pubitemid 37033906)
27. Murphy ME and Sies H (1991) Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc Natl Acad Sci U S A 88:10860-10864.
28. Paolocci N, Jackson MI, Lopez BE, Miranda K, Tocchetti CG, Wink DA, Hobbs AJ, and Fukuto JM (2007) The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO. Pharmacol Ther 113:442-458.
29. Pfeiffer S, Leopold E, Hemmens B, Schmidt K, Werner ER, and Mayer B (1997) Interference of carboxy-PTIO with nitric oxide- and peroxynitrite- mediated reactions. Free Rad Biol Med 22:787-794. (Pubitemid 27058341)
30. -) using L-cysteine. Biochem Biophys Res Commun 201:54-62.
31. Riethmüller C, Gorren AC, Pitters E, Hemmens B, Habisch HJ, Heales SJ, Schmidt K, Werner ER, and Mayer B (1999) Activation of neuronal nitric-oxide synthase by the 5-methyl analog of tetrahydrobiopterin. Functional, evidence against reductive oxygen activation by the pterin cofactor. J Biol Chem 274:16047-16051.
32. Roy B, Mo E, Vernon J, and Garthwaite J (2008) Probing the presence of the ligand-binding haem in cellular nitric oxide receptors. Br J Pharmacol 153:1495-1504.
33. Russwurm M and Koesling D (2005) Purification and characterization of NOsensitive guanylyl cyclase. Methods Enzymol 396:492-501. (Pubitemid 41603570)
34. Schmidt HH, Hofmann H, Schindler U, Shutenko ZS, Cunningham DD, and Feelisch M (1996) No ·NO from NO synthase. Proc Natl Acad Sci U S A 93:14492-14497.
35. Schmidt K and Mayer B (2004) Consumption of nitric oxide by endothelial cells: evidence for the involvement of a NAD(P)H-, flavin- and heme-dependent dioxygenase reaction. FEBS Lett 577:199-204. (Pubitemid 39452384)
36. Schmidt K, Mayer B, and Kukovetz WR (1989) Effect of calcium on endotheliumderived relaxing factor formation and cGMP levels in endothelial cells. Eur J Pharmacol 170:157-166. (Pubitemid 19274643)
37. Schrammel A, Behrends S, Schmidt K, Koesling D, and Mayer B (1996) Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 50:1-5. (Pubitemid 26250067)
38. Shen B and English AM (2005) Mass spectrometric analysis of nitroxyl-mediated protein modification: comparison of products formed with free and protein-based cysteines. Biochemistry 44:14030-14044. (Pubitemid 41507483)
39. Wanstall JC, Jeffery TK, Gambino A, Lovren F, and Triggle CR (2001) Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion. Br J Pharmacol 134:463-472. (Pubitemid 32977891)
40. Zamora R, Grzesiok A, Weber H, and Feelisch M (1995) Oxidative release of nitric oxide accounts for guanylyl cyclase stimulating, vasodilator and antiplatelet activity of Piloty's acid: a comparison with Angeli's salt. Biochem J 312:333-339. (Pubitemid 26002195)